RetinalGenix Technologies (RTGN) Shares Outstanding (2020 - 2026)
RetinalGenix Technologies (RTGN) posted Shares Outstanding (Entity) of $18.8 million for Q1 2026, little changed sequentially from $18.8 million in Q4 2025, and up 1.25% YoY from $18.5 million in Q1 2025.
RetinalGenix Technologies (RTGN) Shares Outstanding (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $18.8 million in Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 1.25% year-over-year to $18.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.8 million (up 1.25% YoY) and the FY2025 annual result came in at $18.8 million, up 1.25% from the prior year.
- Shares Outstanding (Entity) steadied at $18.8 million in Q1 2026 per RTGN's latest filing, from $18.8 million in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $18.8 million in Q4 2025 and troughed at $14.3 million in Q1 2022.
- A 5-year average of $17.5 million and a median of $17.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 65.23% in 2022, then climbed 20.93% in 2023.
- Over 5 years, Shares Outstanding (Entity) stood at $17.3 million in 2022, then grew by 2.1% to $17.6 million in 2023, then advanced by 5.03% to $18.5 million in 2024, then rose by 1.25% to $18.8 million in 2025, then changed by 0.0% to $18.8 million in 2026.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $18.8 million, $18.8 million, and $18.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.31 Bn | 193.71 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 129.55 Bn | 126.08 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 119.91 Bn | 110.69 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 74.06 Bn | 73.52 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.45 Bn | 48.20 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn | 97.60 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 18.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.75 Mn |
| Dec 31, 2025 | 18.56 Mn |
| Sep 30, 2025 | 18.58 Mn |
| Jun 30, 2025 | 18.33 Mn |
| Mar 31, 2025 | 18.52 Mn |
| Dec 31, 2024 | 17.94 Mn |
| Sep 30, 2024 | 17.97 Mn |
| Jun 30, 2024 | 17.86 Mn |
| Mar 31, 2024 | 17.67 Mn |
| Dec 31, 2023 | 17.35 Mn |
| Sep 30, 2023 | 17.28 Mn |
| Jun 30, 2023 | 17.27 Mn |
| Mar 31, 2023 | 17.27 Mn |
| Dec 31, 2022 | 15.58 Mn |
| Sep 30, 2022 | 16.56 Mn |
| Jun 30, 2022 | 14.52 Mn |
| Mar 31, 2022 | 14.28 Mn |
| Dec 31, 2021 | 41.25 Mn |
| Sep 30, 2021 | 41.83 Mn |
| Jun 30, 2021 | 41.03 Mn |